Asymchem Laboratories (Tianjin)'s low P/E ratio may be due to investors' belief in the company's poor earnings performance. The outlook for shrinking earnings contributes to its low P/E, forming a barrier for the share price.
Asymchem Laboratories (Tianjin)'s low P/E ratio is due to predicted declining earnings. Investors see limited potential for earnings improvement, hence a higher P/E ratio isn't justified, indicating a stagnant share price.
$Hang Seng Index(800000.HK)$plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion. Pharmaceuticals were sold off.$REMEGEN-B(09995.HK)$once collapsed 27.5% to $22.8; last at $24.9, down 21%. $CLOVER BIO-B(02197.HK)$nosedived 9.6% to $0.47, hitting record low.$維亜生物科技(01873.HK)$...
Asymchem Laboratoriesに関するコメント
Pharmaceuticals were sold off. $REMEGEN-B(09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$CLOVER BIO-B(02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $維亜生物科技(01873.HK)$ ...
まだコメントはありません